Ghent University Academic Bibliography

Your filters: cql: author="Goyvaerts, Cleo" or (type any "bookEditor issueEditor" and editor="Goyvaerts, Cleo")

Add to list
- Journal Article
- A1
- open access
Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8+ T cell and iNKT cell activating mRNA vaccine

Thomas Ertveldt, Sofie Meulewaeter (UGent) , Yannick De Vlaeminck, Oscar Olarte, Katrijn Broos, Serge Van Calenbergh (UGent) , Stephanie Bourgeois, Joke Deprez (UGent) , Yves Heremans, Cleo Goyvaerts, et al.

(2023) THERANOSTICS. 13(15). p.5483-5500
Add to list
- Journal Article
- A1
- open access
Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade

Robin Maximilian Awad, Quentin Lecocq, Katty Zeven, Thomas Ertveldt, Lien De Beck, Hannelore Ceuppens, Katrijn Broos, Yannick De Vlaeminck, Cleo Goyvaerts, Magali Verdonck, et al.

(2021) MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT. 22. p.172-182
Add to list
- Journal Article
- A1
- open access
Hepatocarcinoma induces a tumor necrosis factor-dependent Kupffer cell death pathway that favors its proliferation upon partial hepatectomy

Jean-François Hastir (UGent) , Sandrine Delbauve, Lionel Larbanoix, Desislava Germanova, Cleo Goyvaerts, Justine Allard, Sophie Laurent, Karine Breckpot, Alain Beschin, Martin Guilliams (UGent) , et al.

(2020) FRONTIERS IN ONCOLOGY. 10.
Add to list
- Journal Article
- A2
- open access
Particle-mediated intravenous delivery of antigen mRNA results in strong antigen-specific T-cell responses despite the induction of type I interferon

Katrijn Broos, Kevin Vanderjeught, Janik Puttemans, Cleo Goyvaerts, Carlo Heirman, Heleen Dewitte (UGent) , Rein Verbeke (UGent) , Ine Lentacker (UGent) , Kris Thielemans and Karine Breckpot

(2016) MOLECULAR THERAPY-NUCLEIC ACIDS. 5.
Add to list
- Journal Article
- A1
Intratumoral delivery of TriMix mRNA results in T-cell activation by cross-presenting dendritic cells

Sandra Van Lint (UGent) , Dries Renmans, Katrijn Broos, Lode Goethals, Sarah Maenhout, Daphné Benteyn, Cleo Goyvaerts, Stephanie Dufour, Kevin Van Der Jeught, Lukasz Bialkowski, et al.

(2016) CANCER IMMUNOLOGY RESEARCH. 4(2). p.146-156
Add to list
- Journal Article
- A1
- open access
Targeting the tumor microenvironment to enhance antitumor immune responses

Kevin Van Der Jeught, Lukasz Bialkowski, Lidia Daszkiewicz, Katrijn Broos, Cleo Goyvaerts, Dries Renmans, Sandra Van Lint (UGent) , Carlo Heirman, Kris Thielemans and Karine Breckpot

(2015) ONCOTARGET. 6(3). p.1359-1381
Add to list
- Journal Article
- A1
- open access
Immunogenicity of targeted lentivectors

Cleo Goyvaerts, Kurt De Groeve, Sandra Van Lint (UGent) , Carlo Heirman, Jo A Vanginderachter, Patrick De Baetselier, Geert Raes, Kris Thielemans and Karine Breckpot

(2014) ONCOTARGET. 5(3). p.704-715
Add to list
Proinflammatory characteristics of SMAC/DIABLO-induced cell death in antitumor therapy

Perpetua U Emeagi, Sandra Van Lint (UGent) , Cleo Goyvaerts, Sarah Maenhout, Anje Cauwels (UGent) , Lain A McNeish, Tomas Bos, Carlo Heirman, Kris Thielennans, Joeri L Aerts, et al.

(2012) CANCER RESEARCH. 72(6). p.1342-1352
Add to list
- Journal Article
- A1
- open access
Development of the nanobody display technology to target lentiviral vectors to antigen-presenting cells

Cleo Goyvaerts, Kurt De Groeve, Jozef Dingemans, Sandra Van Lint (UGent) , Lander Robays, Carlo Heirman, J Reiser, Kris Thielemans, Patrick De Baetselier, Geert Raes, et al.

(2012) GENE THERAPY. 19(12). p.1133-1140
Add to list
Preclinical evaluation of TriMix and antigen mRNA-based anti-tumor therapy

Sandra Van Lint (UGent) , Cleo Goyvaerts, Sarah Maenhout, Lode Goethals, Aurélie Disy, Daphné Benteyn, Joeri Pen, Aude Bonehill, Carlo Heirman, Karine Breckpot, et al.

(2012) CANCER RESEARCH. 72(7). p.1661-1671

Academic Bibliography

Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8+ T cell and iNKT cell activating mRNA vaccine

Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade

Hepatocarcinoma induces a tumor necrosis factor-dependent Kupffer cell death pathway that favors its proliferation upon partial hepatectomy

Particle-mediated intravenous delivery of antigen mRNA results in strong antigen-specific T-cell responses despite the induction of type I interferon

Intratumoral delivery of TriMix mRNA results in T-cell activation by cross-presenting dendritic cells

Targeting the tumor microenvironment to enhance antitumor immune responses

Immunogenicity of targeted lentivectors

Proinflammatory characteristics of SMAC/DIABLO-induced cell death in antitumor therapy

Development of the nanobody display technology to target lentiviral vectors to antigen-presenting cells

Preclinical evaluation of TriMix and antigen mRNA-based anti-tumor therapy

Contents

Support

Contact